Amanda Machalle Schleuss, PHARMD is a
Pharmacist based in Berryville, Virginia. Amanda Machalle Schleuss is licensed to practice in Virginia (license number 0202211677) and her current practice location is
15a Crow St, Berryville, Virginia. She can be reached at her office (for appointments etc.) via phone at
(540) 955-2020.
NPI number for Amanda Machalle Schleuss is 1861737488 and her current mailing address is 15a Crow St, Berryville, Virginia. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1861737488.
Healthcare Provider's Profile
Full Name | Amanda Machalle Schleuss |
---|
Gender | Female |
---|
Speciality | Pharmacist |
---|
Location | 15a Crow St, Berryville, Virginia |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1861737488
- Provider Enumeration Date: 12/07/2012
- Last Update Date: 12/07/2012
Medical Identifiers
Medical identifiers for Amanda Machalle Schleuss such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1861737488 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
183500000X | Pharmacist | 0202211677 (Virginia) | Primary |
183500000X | Pharmacist | 0007994 (West Virginia) | Secondary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Amanda Machalle Schleuss is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Amanda Machalle Schleuss, PHARMD 15a Crow St, Berryville, VA 22611-1327 Ph: (540) 955-2020 | Amanda Machalle Schleuss, PHARMD 15a Crow St, Berryville, VA 22611-1327 Ph: (540) 955-2020 |
Reviews and Comments